In summary, our research offered a new theoretical foundation for the HCC treatment by indicating that regulatory factor X‐5 (RFX5) phosphate buffer saline and STIL might be novel therapeutic targets for HCC. The gene discussed is RFX5; the disease is hepatocellular carcinoma.